American Society of Interventional Pain Physicians News | May 11, 2016
Room Block for Memphis ASIPP Courses in June Expires Next Week!
Disc Decompression, Imaging, Controlled Substance, Practice Management, and Interventional Techniques
Here is an overview of the June schedule of meetings that ASIPP has in store for you! Meeting Brochures and Registration will be available soon!
Lumbar Endoscopic Spinal Decompression Hands-on Cadaver Workshop and Online Lectures
Click HERE to register
Click HERE to view brochure
Comprehensive Review of Interventional Techniques and Hands on Cadaver Workshop
Basic, Intermediate and Advanced Interventional Techniques
Two days of didactics and 1 1/2 days of hands-on training in the cadaver lab. New and revised content!
Click HERE to register
Click HERE to view brochure
Comprehensive Imaging Review in Interventional Pain Management and Competency Examination
to view brochure
Comprehensive Review Course of Controlled Substance Management and Practice Management and Competency Examinations
Take CSM, CCPM, or a combined examination
Take one or both!
Click HERE to Register
Click HERE to view brochure
ABIPP Part I Examination - June 11
250 North Main Street
, TN, 38103
ABIPP Certification Made Simple
The American Board of Interventional Pain Physicians (ABIPP) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified. ABIPP is recognized in 11 states. Ten states have no statutes governing specialty boards. Approval is pending in remaining states.
ABIPP is a Specialty Board providing certifications in the following areas:
Board Certification in Interventional Pain Management
Either with ABMS pain medicine board certification or ABMS primary certification only
Competency Certification in:
* Interventional Pain Management
* Regenerative Medicine
* Controlled Substance Management
* Coding, Compliance, and Practice Management
* Fluoroscopic Interpretation and Radiological Safety
* Endoscopic Spinal Decompression
Click HERE to view Pathway to ABIPP Certification
ICD-10 Book Now Available: Order Your Copy Today!
The initial impression of ICD-10 implementation was that it went well for both providers and CMS, however, shortly after the October 1, 2015 date when Medicare claims began processing, providers found out otherwise. In some cases, Interventional Pain Management providers continue to struggle with "finding the right code" to report for their patient's condition.
CMS released a publication "Clarifying Questions and Answers Related to the July 6, 2015 CMS/AMA Joint Announcement and Guidance Regarding ICD-10 Flexibilities" http://tinyurl.com/CMS-ICD-10-ClarifyQ-A that provided additional details as to how this ICD-10 family of codes "free pass" was going to work.
In short, CMS stated, "The recent Guidance does not change the coding specificity required by the NCDs and LCDs. Coverage policies that currently require a specific diagnosis under ICD-9 will continue to require a specific diagnosis under ICD-10. It is important to note that these policies will require no greater specificity in ICD-10 than was required in ICD-9, with the exception of laterality, which does not exist in ICD-9. LCDs and NCDs that contain ICD-10 codes for right side, left side or bilateral do not allow for unspecified side."
What this means is that:
- Interventional Pain Management providers are still being held responsible for reporting the correct ICD-10 code or risk Medicare claims denials.
- Many Interventional Pain Management procedures are included in the various Medicare contractor's Local Coverage Policies (LCD) and include very specific lists of ICD-10 codes that meet medical necessity for the diagnostic and therapeutic procedures.
- In some cases, Medicare contractors have separate LCD policies for each type of interventional pain procedure and often multiple pages in length.
Don't be one of the providers that have the misunderstanding if they report a valid ICD-10-CM code in the same family of codes, Medicare will accept that.
Busy Interventional Pain Management providers don't have time to check the Medicare LCD each time they perform a procedure.
Make your medical practice easier and use the ASIPP® new ICD-10-CM Pocket Guide for assistance navigating through the complexity of ICD-10 coding.
This book is 5.25 x 8.25 and can easily be placed in your jacket or any carrying case. For only $400 you will receive both the electronic and paper versions. You can recover your cost by avoiding mistakes in just one single case.
Order immediately to avoid any future losses. Get it for yourself and get copies for all your partners and staff. Multiple copies can be transferred to your EMR and save you money.
Also take a 10% discount for 5-9 copies or a 20% discount for 10 copies or more.
Medicare Overpayment Overview Webinar May 25
Presenter: Vicki Myckowiak, Esq.of Myckowiak Associates, PC
May 25, 2016 | 11:00am-12:30pm CST
When physician practice discovers that they have been overpaid by Medicare
they must report and return the overpayment within 60 days.
Overpayments can include:
- Payments for services that do not meet medical necessity guidelines
- Payments for services that are incorrectly coded or billed
- Payments for noncovered services
- Duplicate payments
On February 12, 2016 the federal government published new rules on the reporting and repayment of overpayments. Failure to comply can lead to significant fines and penalties.
What should you do?
Join Vicki Myckowiak for a hands-on practical webinar dedicated to helping
interventional pain physicians navigate the complicated repayment rules
ASIPP Addresses Publications Controversy
In recent months, there has been substantial controversy with publications in interventional pain management. We have spoken on multiple occasions on this issue. The most recent articles have been by Chou et al published by AHRQ and also published in Annals of Internal Medicine. We have responded to them in the form of letters to the editor, editorial in Evidence Based Medicine, and a manuscript showing the discrepancies and also flawed analysis of the evidence by
Chou et al.
In addition to this, we also have published multiple systematic reviews assessing all types of epidural injections in all 3 regions, not only in Pain Physician, but also multiple other journals. These include:
Manchikanti L, Nampiaparampil DE, Manchikanti KN, Falco FJE, Singh V, Benyamin RM, Kaye AD, Sehgal N, Soin A, Simopoulos TT, Bakshi S, Gharibo CG, Gilligan CJ, Hirsch JA. Comparison of the efficacy of saline, local anesthetics, and steroids in epidural and facet joint injections for the management of spinal pain: A systematic review of randomized controlled trials. Surg Neurol Int 2015; 6:S194-S235.
Kaye AD, Manchikanti L, Abdi S, Atluri S, Bakshi S, Benyamin R, Boswell MV, Buenaventura R, Candido KD, Cordner HJ, Datta S, Doulatram G, Gharibo CG, Grami V, Gupta S, Jha S, Kaplan ED, Malla Y, Mann DP, Nampiaparampil DE, Racz G, Raj P, Rana MV, Sharma ML, Singh V, Soin A, Staats PS, Vallejo R, Wargo BW, Hirsch JA. Efficacy of epidural injections in managing chronic spinal pain: A best evidence synthesis. Pain Physician 2015; 18:E939-E1004.
If you need a full manuscript, please contact us at email@example.com.
It is important for all the interventional pain physicians to understand to defend activities of individuals with major conflicts and policy-makers.
Prince's Death Spotlights Overdose Antidote Dilemma
Prince's death last month from a possible opioid overdose highlights the challenge for health officials using the overdose-reversal medication naloxone: getting people saved from overdoses into addiction treatment.
Six days before he died, the 57-year-old musician overdosed on the painkiller Percocet while on a flight, forcing the plane to make an emergency landing in Moline, Ill., a law-enforcement official said.
Access to this site may be limited.
Long-term care costs continue to rise
Long-term care grew more expensive again this year, with the cost of the priciest option, a private nursing home room, edging closer to $100,000 annually, according to a survey from Genworth Financial.
Americans also are paying more for other care options like home health aides and assisted living communities, while adult day care costs fell slightly compared to 2015, Genworth reported in a study released Tuesday.
Private nursing home rooms now come with a median annual bill of $92,378, an increase of 1.2% from last year and nearly 19% since 2011. That breaks down to a monthly bill of $7,698.
Chronic Pain After Mastectomy: A Common and Challenging Pain Syndrome
For many women, the pain of breast cancer does not end after surgery, and chronic pain after mastectomy-termed postmastectomy pain syndrome (PMPS)-can be mentally and physically debilitating.
"Studies have shown that between 20% and 30% of women develop symptoms of PMPS after surgery. This number varies in the literature," says Susan K. Boolbol, MD, chief of breast surgery at Mount Sinai Beth Israel, and clinical director of the Cancer Network at the Mount Sinai Health System in New York City.
CMS approves IMQ as new ASC accrediting agency
This final notice announces our decision to approve the Institute for Medical Quality (IMQ) for recognition as a national accrediting organization for ambulatory surgical centers (ASCs) that wish to participate in the Medicare or Medicaid programs. An ASC that participates in Medicaid must also meet the Medicare conditions for coverage (CfCs) as required under our regulations.
Addicts Take Diarrhea Drug Imodium to Get High
In their search for alternatives to opioid painkillers like Oxycontin and Vicodin, addicts are turning to the over-the-counter anti-diarrhea drug Imodium to get their fix. Researchers have found that Imodium's key ingredient, loperamide, is the culprit feeding addicts' high.
The study highlighted two case studies of patients with histories of substance abuse who also attempted to handle their opioid addictions with large doses of loperamide.
Novel Opioid Not Abuse-Deterrent, FDA Panel Says
-- At a joint FDA advisory committee meeting Thursday, members voted that an immediate-release version of a hydrocodone/acetaminophen combination product could be approved, but it shouldn't get abuse-deterrent labeling.
Panelists voted 16-4 that benzhydrocodone/acetaminophen (6.67 mg/325 mg), or KP201 (Apadaz), proved bioequivalence to similar products on the market, but voted 18-2 that evidence to demonstrate abuse deterrence -- focused mostly on preventing the drug from being snorted -- were lacking.
Research Update on Migraine Preventive Medicine
In a systematic review published in Headache, Patniyot IR, et al
summarizes the evidence for acute therapies for
in the pediatric population, especially in the emergency department (ED) setting. A total of 31 articles were included in the final review. The primary measure of efficacy was pain-free at 2 hours. Seventeen of these studies were randomized controlled trials, 9 were retrospective reviews, and 5 were prospective chart reviews. The medications reviewed in those studies included IV fluids, analgesics, dopamine receptor antagonists, valproic acid, propofol, magnesium, bupivacaine, triptans, and dihydroergotamine (DHE).
One study examined the use of intravenous fluids for headache without any other added medication. This treatment showed some efficacy, as many patients can have nausea and subsequently decreased oral intake, which can lead to dehydration. Acetaminophen and ibuprofen, both commonly used for headache, were compared in one randomized trial against placebo. Ibuprofen was found to be most helpful in relieving headache at 2 hours, although acetaminophen was also superior to placebo. A number of dopamine receptor antagonists were also studied. One of them, prochlorperazine, was studied in a retrospective review in which 80% of participants reported headache resolution at 1 hour. Similar results were observed in 3 other studies for other phenothiazines.
FDA takes significant steps to protect Americans from dangers of tobacco through new regulation
Today, the U.S. Food and Drug Administration finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others. This historic rule helps implement the bipartisan Family Smoking Prevention and Tobacco Control Act of 2009 and allows the FDA to improve public health and protect future generations from the dangers of tobacco use through a variety of steps, including restricting the sale of these tobacco products to minors nationwide.
"We have more to do to help protect Americans from the dangers of tobacco and nicotine, especially our youth. As cigarette smoking among those under 18 has fallen, the use of other nicotine products, including e-cigarettes, has taken a drastic leap. All of this is creating a new generation of Americans who are at risk of addiction," said HHS Secretary Sylvia Burwell. "Today's announcement is an important step in the fight for a tobacco-free generation - it will help us catch up with changes in the marketplace, put into place rules that protect our kids and give adults information they need to make informed decisions."
Opioids Not Cost-Effective in OA
Incorporating opioids into the treatment of knee osteoarthritis (OA) was not cost-effective as the drugs had a negative impact on the long-term outcome in patients destined for total knee arthroplasty (TKA), researchers reported.
Tramadol with or without oxycodone increased cost and decreased quality-adjusted life-years (QALYs) compared with an opioid-sparing strategy in knee OA patients with persistent pain despite conservative treatment, according to Elena Losina, PhD, of Brigham and Women's Hospital and Harvard University in Boston.
State Society News
FSIPP Annual Meeting
May 20-22, 2016
The Florida Society of Interventional Pain Physicians will hold its annual meeting in 2016 on May 20-22.
The 2016 Annual Meeting, Conference and Trade Show
Interventional Pain Management:
A Diagnostic and Therapeutic Pathway to Restoration of Function
will be held at the
8701 World Center Drive, Orlando, FL 32821
FSIPP is also offering 2 concurrent programs:
- Safe Opiate Prescribing Course - no charge, but you need to be registered for the annual meeting.
- The Business of Pain Course on Saturday, May 21 - $150.00
Please send your State Society meetings and news to: Holly Long at firstname.lastname@example.org
To view or post a job, please go to: http://jobs.asipp.org/home
To receive a member discount for posting a job, use member code: 20Member